FARSLB Inhibitors

FARSLB inhibitors primarily work by targeting the intricate mechanisms of protein translation, either directly or indirectly affecting the function and efficiency of FARSLB, an essential component of the aminoacyl-tRNA synthetase complex. Halofuginone, Borrelidin, Mupirocin, and Cladosporin are notable examples that directly inhibit specific tRNA synthetases, reflecting the interwoven nature of the synthetase family where disruption to one member can ripple effects to others like FARSLB. Other inhibitors, like Anisomycin, Macrolides, Aminoglycosides, Fusidic Acid, Cycloheximide, and Puromycin, adopt a more encompassing approach. By acting on various stages of the protein synthesis machinery, they establish a disrupted environment where the equilibrium and functionality of FARSLB can be indirectly compromised. Anisomycin, for instance, hinders peptide bond formation, while Tetracyclines and Macrolides focus on ribosomal subunits, essential structures in protein synthesis. Aminoglycosides, on the other hand, perturb the initiation and elongation processes of translation.